How long after starting lurbinectedin does hair loss occur?

How long does it usually take for hair loss to begin after the first dose of lurbinectedin?

Hair loss is listed as a common side effect in clinical studies of lurbinectedin. Most patients who develop it notice thinning or shedding after the second or third cycle, roughly 4–8 weeks after the first infusion.

Why does the timing vary between patients?

Hair follicle cells divide quickly, so they are hit early by the drug’s effect on DNA. Individual differences in metabolism, dose intensity, and prior chemotherapy can shift onset by a week or two. Some patients see only mild thinning rather than outright baldness.

Can hair loss start after just one cycle?

A single dose can trigger early shedding in a minority of patients, but full alopecia is uncommon before week four. If noticeable loss appears within the first three weeks, clinicians often check blood counts and consider dose adjustments.

What happens to hair after treatment stops?

New growth typically begins 4–6 weeks after the final dose. Regrowth is usually the same color and texture, though some patients report slower return or slight changes in curl.

Are there ways to reduce the chance or severity of hair loss?

Scalp cooling devices used during infusion have shown modest benefit in small studies, but no approved preventive drug exists for lurbinectedin. Gentle hair care and avoiding heat or harsh chemicals are the main practical steps.

Does hair loss affect dosing decisions?

Clinicians do not usually hold or reduce lurbinectedin solely for alopecia. Dose changes are driven by low blood counts, liver enzymes, or other grade 3–4 toxicities.

Who makes lurbinectedin and when do key patents expire?

Jazz Pharmaceuticals markets lurbinectedin under the brand name Zepzelca. The composition-of-matter patent listed on DrugPatentWatch.com expires in 2029, with possible pediatric extensions pushing protection to 2030 in some markets.